Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
7.36
0.10 (1.38%)
At close: Aug 15, 2025, 3:59 PM
7.38
0.27%
After-hours: Aug 15, 2025, 04:10 PM EDT
Contineum Therapeutics Class A Common Stock Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Cash & Equivalents | 20.78M | 22.47M | 21.94M | 40.89M | 77.23M | 16.26M | 15.53M | 17.52M | -47.24M | 5.57M |
Short-Term Investments | 154.7M | 168.24M | 182.82M | 173.02M | 141.42M | 101.64M | 109.66M | 117.6M | 94.48M | 41.67M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 186K | 4K | 3K | 3K | 3K | 2.62M | 1.28M | 155K | -47.24M | 129K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.35M | 1.42M | 1.63M | 1.23M | 1.67M | 1.8M | 2.52M | 2.4M | n/a | 1.15M |
Total Current Assets | 176.84M | 192.13M | 206.39M | 215.14M | 220.32M | 119.71M | 127.71M | 137.53M | 47.24M | 48.39M |
Property-Plant & Equipment | 5.86M | 6.13M | 6.46M | 888K | 1.03M | 1.23M | 1.4M | 1.36M | n/a | 2.12M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 6.05M | 6.13M | 6.46M | 891K | 1.03M | 3.85M | 2.68M | 1.52M | -47.24M | 2.24M |
Total Assets | 182.89M | 198.26M | 212.85M | 216.03M | 221.35M | 123.56M | 130.39M | 139.04M | n/a | 50.64M |
Account Payables | 2M | 3.65M | 1.81M | 1.4M | 734K | 570K | 635K | 1.05M | n/a | 430K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.47M | n/a | n/a | n/a | 484K | 474K | n/a | n/a | n/a | 3.95M |
Other Current Liabilities | 1.98M | 1.19M | 3.37M | 2.18M | 918K | 3.76M | 2.48M | 1.5M | n/a | 752K |
Total Current Liabilities | 7.21M | 8.95M | 9.97M | 5.81M | 3.74M | 6.23M | 5.48M | 7.44M | n/a | 7.55M |
Long-Term Debt | 4.28M | n/a | n/a | n/a | n/a | 111K | 192.62M | n/a | n/a | 132.48M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 192.74M | 110K | 192.75M | n/a | 3.02M |
Total Long-Term Liabilities | 4.28M | 4.55M | 4.81M | n/a | 113K | 192.96M | 192.84M | 192.75M | n/a | 136.3M |
Total Liabilities | 11.5M | 13.5M | 14.78M | 5.81M | 3.85M | 199.19M | 198.32M | 200.19M | n/a | 143.85M |
Total Debt | 5.75M | 6M | 6.26M | 611K | 597K | 193.21M | 193.19M | 1.12M | n/a | 138.33M |
Common Stock | 26K | 26K | 26K | 26K | 26K | 2K | 13K | 13K | n/a | 12K |
Retained Earnings | -149.43M | -133.39M | -117.4M | -102.84M | -92.57M | -83.56M | -75.14M | -67.38M | n/a | -97.86M |
Comprehensive Income | 147K | 170K | 71K | 561K | -127K | -58K | 108K | -89K | -93.21M | -76K |
Shareholders Equity | 171.39M | 184.77M | 198.07M | 210.23M | 217.5M | -75.63M | -67.94M | -61.14M | 39.27M | -93.21M |
Total Investments | 154.7M | 168.24M | 182.82M | 173.02M | 141.42M | 101.64M | 109.66M | 117.6M | 94.48M | 41.67M |